PTGX – Protagonist Therapeutics Inc
Protagonist Therapeutics, Inc.PTGX
$53.83Name : Protagonist Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,336,550,400.00
EPSttm : 0.78
Protagonist Therapeutics, Inc.
$53.83
0.06%$0.03Float Short %
10.59
Margin Of Safety %
34
Put/Call OI Ratio
0.26
EPS Next Q Diff
-0.35
EPS Last/This Y
-6.12
EPS This/Next Y
0.48
Price
53.83
Target Price
68.42
Analyst Recom
1.17
Performance Q
19.65
Relative Volume
0.71
Beta
2.33
Ticker: PTGX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-07 | PTGX | 49.87 | 0.93 | 0.94 | 8508 |
| 2025-07-08 | PTGX | 49.7 | 0.93 | 0.37 | 8512 |
| 2025-07-09 | PTGX | 52.3 | 0.94 | 0.02 | 8467 |
| 2025-07-10 | PTGX | 52.86 | 0.93 | 0.10 | 8508 |
| 2025-07-11 | PTGX | 53.01 | 0.93 | 1.74 | 8518 |
| 2025-07-14 | PTGX | 55.23 | 0.92 | 15.70 | 8454 |
| 2025-07-15 | PTGX | 55.35 | 0.92 | 4.88 | 8429 |
| 2025-07-16 | PTGX | 56.63 | 0.90 | 0.14 | 8240 |
| 2025-07-17 | PTGX | 56.48 | 0.90 | 0.47 | 8231 |
| 2025-07-18 | PTGX | 55.48 | 0.90 | 0.00 | 8330 |
| 2025-07-21 | PTGX | 55.22 | 0.51 | 0.03 | 1535 |
| 2025-07-22 | PTGX | 54.99 | 0.31 | 0.00 | 2319 |
| 2025-07-23 | PTGX | 54.21 | 0.30 | 0.23 | 2367 |
| 2025-07-24 | PTGX | 53.9 | 0.26 | 0.00 | 3054 |
| 2025-07-25 | PTGX | 55.17 | 0.25 | 0.00 | 3157 |
| 2025-07-28 | PTGX | 56.28 | 0.25 | 0.15 | 3157 |
| 2025-07-29 | PTGX | 55.01 | 0.25 | 0.15 | 3157 |
| 2025-07-30 | PTGX | 54.55 | 0.25 | 5.50 | 3169 |
| 2025-07-31 | PTGX | 53.85 | 0.26 | 0.25 | 3208 |
| 2025-08-01 | PTGX | 53.8 | 0.26 | 1.00 | 3216 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-07 | PTGX | 49.88 | -5.0 | - | -1.65 |
| 2025-07-08 | PTGX | 49.70 | -5.0 | - | -1.65 |
| 2025-07-09 | PTGX | 52.29 | -5.0 | - | -1.65 |
| 2025-07-10 | PTGX | 52.83 | -5.0 | - | -1.65 |
| 2025-07-11 | PTGX | 53.00 | -5.0 | - | -1.65 |
| 2025-07-14 | PTGX | 55.23 | -5.0 | - | -1.65 |
| 2025-07-15 | PTGX | 55.32 | -5.0 | - | -1.65 |
| 2025-07-16 | PTGX | 56.65 | -5.0 | - | -1.65 |
| 2025-07-17 | PTGX | 56.44 | -5.0 | - | -1.65 |
| 2025-07-18 | PTGX | 55.47 | -5.0 | - | -1.65 |
| 2025-07-21 | PTGX | 55.23 | -5.0 | - | -1.65 |
| 2025-07-22 | PTGX | 54.96 | -5.0 | - | -1.65 |
| 2025-07-23 | PTGX | 54.19 | -5.0 | - | -1.65 |
| 2025-07-24 | PTGX | 53.74 | -5.0 | - | -1.65 |
| 2025-07-25 | PTGX | 55.15 | -5.0 | - | -1.65 |
| 2025-07-28 | PTGX | 56.20 | -5.0 | - | -1.65 |
| 2025-07-29 | PTGX | 55.01 | -5.0 | - | -1.65 |
| 2025-07-30 | PTGX | 54.62 | -5.0 | - | -1.65 |
| 2025-07-31 | PTGX | 53.86 | -5.0 | - | -1.65 |
| 2025-08-01 | PTGX | 53.83 | -5.0 | - | -1.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-07 | PTGX | -2.33 | -0.32 | 10.13 |
| 2025-07-08 | PTGX | -2.33 | -0.32 | 10.13 |
| 2025-07-09 | PTGX | -2.33 | -0.32 | 10.13 |
| 2025-07-10 | PTGX | -2.33 | -0.32 | 10.13 |
| 2025-07-11 | PTGX | -2.33 | -0.32 | 11.54 |
| 2025-07-14 | PTGX | -2.33 | -0.36 | 11.54 |
| 2025-07-15 | PTGX | -2.33 | -0.36 | 11.54 |
| 2025-07-16 | PTGX | -2.33 | -0.36 | 11.54 |
| 2025-07-17 | PTGX | -2.33 | -0.36 | 11.54 |
| 2025-07-18 | PTGX | -2.33 | -0.36 | 11.54 |
| 2025-07-21 | PTGX | -2.33 | -0.39 | 11.54 |
| 2025-07-22 | PTGX | -2.33 | -0.39 | 11.54 |
| 2025-07-23 | PTGX | -2.33 | -0.39 | 11.54 |
| 2025-07-24 | PTGX | -3.69 | -0.39 | 11.54 |
| 2025-07-25 | PTGX | -3.69 | -0.39 | 10.60 |
| 2025-07-28 | PTGX | -3.69 | -0.42 | 10.59 |
| 2025-07-29 | PTGX | -3.98 | -0.42 | 10.59 |
| 2025-07-30 | PTGX | -3.98 | -0.42 | 10.59 |
| 2025-07-31 | PTGX | -3.98 | -0.42 | 10.59 |
| 2025-08-01 | PTGX | -4.00 | -0.42 | 10.59 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.5
Avg. EPS Est. Next Quarter
-0.54
Insider Transactions
-4
Institutional Transactions
-0.42
Beta
2.33
Average Sales Estimate Current Quarter
8
Average Sales Estimate Next Quarter
8
Fair Value
72.12
Quality Score
57
Growth Score
58
Sentiment Score
24
Actual DrawDown %
11.2
Max Drawdown 5-Year %
-85.8
Target Price
68.42
P/E
70.76
Forward P/E
PEG
P/S
16.06
P/B
4.84
P/Free Cash Flow
9.95
EPS
0.76
Average EPS Est. Cur. Y
-1.65
EPS Next Y. (Est.)
-1.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
27.04
Relative Volume
0.71
Return on Equity vs Sector %
-15.6
Return on Equity vs Industry %
3.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.11
EBIT Estimation
Protagonist Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 124
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
stock quote shares PTGX – Protagonist Therapeutics Inc Stock Price stock today
news today PTGX – Protagonist Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PTGX – Protagonist Therapeutics Inc yahoo finance google finance
stock history PTGX – Protagonist Therapeutics Inc invest stock market
stock prices PTGX premarket after hours
ticker PTGX fair value insiders trading